Sanctuary Advisors’s GSK GSK Stock Holding History

Sanctuary Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Sell	205,188 -2,619	-1%	-$139K	0.05%	388
2026 Q1	$11.5M	Sell	207,807 -21,208	-9%	-$1.15M	0.06%	336
2025 Q4	$11.2M	Buy	229,015 +5,019	+2%	+$234K	0.06%	319
2025 Q3	$9.67M	Buy	223,996 +8,490	+4%	+$332K	0.06%	348
2025 Q2	$8.28M	Buy	215,506 +31,621	+17%	+$1.21M	0.05%	367
2025 Q1	$7.12M	Sell	183,885 -70,187	-28%	-$2.57M	0.05%	381
2024 Q4	$8.98M	Sell	254,072 -18,488	-7%	-$666K	0.06%	342
2024 Q3	$9.26M	Buy	272,560 +577	+0.2%	+$23.6K	0.06%	329
2024 Q2	$11.2M	Buy	+271,983	New	+$11.4M	0.08%	262

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sanctuary Advisors's GSK Position: Q2 2026 in Review

Sanctuary Advisors reduced its GSK (GSK) stake by 1.3% in Q2 2026, selling an estimated $139K and leaving 205,188 shares worth $10.8M. The position accounts for 0.05% of the portfolio, ranked #388.

Sanctuary Advisors first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.5M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Sanctuary Advisors held 205,188 shares of GSK worth $10.8M as of Q2 2026.
Sanctuary Advisors sold 2,619 GSK shares in Q2 2026, an estimated $139K.
GSK made up 0.05% of Sanctuary Advisors's portfolio in Q2 2026, its #388 holding.
Sanctuary Advisors first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Sanctuary Advisors's GSK position peaked at $11.5M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.